Drug Shortage Report for PENTAMIDINE ISETIONATE FOR INJECTION BP
| Report ID | 273916 |
| Drug Identification Number | 02517663 |
| Brand name | PENTAMIDINE ISETIONATE FOR INJECTION BP |
| Common or Proper name | PENTAMIDINE FOR INJECTION 300MG/VIAL |
| Company Name | MARCAN PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PENTAMIDINE ISETIONATE |
| Strength(s) | 300MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR |
| Packaging size | PACK X 5 VIALS |
| ATC code | P01CX |
| ATC description | AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2025-12-11 |
| Actual start date | 2025-12-11 |
| Estimated end date | 2026-01-15 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2025-12-10 |
| Company comments | Marcan regrets to advise that due to production delays, there will be a temporary supply interruption for this product. Limited inventory remains available at CPDN and McKesson; however, all stock is currently subject to full preventative allocation. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2 GURDWARA RD., SUITE 400 OTTAWA, ONTARIO CANADA K2E 1A2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-12-10 | French | Compare |
| v2 | 2025-12-10 | English | Compare |
| v1 | 2025-12-10 | English | Compare |
Showing 1 to 3 of 3